Pioglitazone Teva Generics (pioglitazone)
Generic
- Region
- 🇪🇺 EU
- Active substance
- pioglitazone
- Company
- Teva Pharma B.V.
- Status
- Application withdrawn
- Therapeutic area
- Diabetes Mellitus, Type 2
- Designations
- Generic
- Application
- EMEA/H/C/002448
- ATC
- A10BG03
- Official record
- www.ema.europa.eu
Indication
Treatment of type 2 diabetes mellitus
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Competact Authorised · CHEPLAPHARM Arzneimittel GmbH
- 🇪🇺 Pioglitazone Accord Authorised · Accord Healthcare S.L.U.
- 🇪🇺 Tandemact Authorised · CHEPLAPHARM Arzneimittel GmbH
- 🇪🇺 Pioglitazone Actavis Authorised · Actavis Group PTC ehf
- 🇪🇺 Actos Authorised · CHEPLAPHARM Arzneimittel GmbH
- 🇪🇺 Pioglitazone Teva Withdrawn · Teva B.V.
- 🇪🇺 Glustin Withdrawn · Takeda Pharma A/S
- 🇪🇺 Glubrava Withdrawn · Takeda Pharma A/S
- 🇪🇺 Incresync Authorised · Takeda Pharma A/S
- 🇪🇺 Glidipion (previously Pioglitazone Actavis Group) Withdrawn · Actavis Group PTC ehf
- 🇪🇺 Pioglitazone Teva Pharma Withdrawn · Teva Pharma B.V.
- 🇪🇺 Pioglitazone Krka Withdrawn · KRKA tovarna zdravil d.d. Novo mesto
Follow Pioglitazone Teva Generics
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.